Geoffrey Wade Smith - Director at Orchestra BioMed Holdings, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
OBIO on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Geoffrey Wade Smith since 10/2/2023

Holdings reported by Geoffrey Wade Smith for Orchestra BioMed Holdings, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1.05M $16.8M $16.04 Jan 26, 2023 By Ascent Biomedical Ventures II, LP
Common Stock 257K $4.12M $16.04 Jan 26, 2023 By Ascent Biomedical Ventures Synecor, LP
Common Stock 201K $3.23M $16.04 Jan 26, 2023 By Ascent Biomedical Ventures II NY, LP
Common Stock, par value $0.0001 per share ("Common Stock") 20.9K $99.3K $4.75 Jul 20, 2023 Direct
Common Stock 3.49K $55.9K $16.04 Jan 26, 2023 Direct
Right to Receive Earnout Shares 228K Apr 12, 2023 By Ascent Biomedical Ventures II, LP Common Stock
Warrants (Right to Buy) 136K Jan 26, 2023 By Ascent Biomedical Ventures II, LP Common Stock
Right to Receive Earnout Shares 55.8K Apr 12, 2023 By Ascent Biomedical Ventures Synecor, LP Common Stock
Warrants (Right to Buy) 43.9K Jan 26, 2023 By Ascent Biomedical Ventures II NY, LP Common Stock
Right to Receive Earnout Shares 43.8K Apr 12, 2023 By Ascent Biomedical Ventures II NY, LP Common Stock
Stock Options (Right to Buy) 23.3K Jan 26, 2023 Direct Common Stock
Warrants (Right to Buy) 15K Jan 26, 2023 Direct Common Stock 15K
Right to Receive Earnout Shares 758 Apr 12, 2023 Direct Common Stock
Warrants (Right to Buy) 519 Jan 26, 2023 By Ascent Biomedical Ventures Synecor, LP Common Stock

Transactions reported by Geoffrey Wade Smith for Orchestra BioMed Holdings, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.